Xeris Biopharma Holdings Investor Relations Material
Latest events
Investor Day 2025
Xeris Biopharma Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xeris Biopharma Holdings Inc
Access all reports
Xeris Biopharma Holdings Inc. is a pharmaceutical company focused on developing and commercializing innovative therapies for patients with endocrine and metabolic disorders, as well as other conditions requiring injectable treatments. The company's technology platform enables the formulation of ready-to-use injectable medications that do not require reconstitution, refrigeration, or complex preparation. The company is headquartered in Chicago, Illinois, and its shares are listed on the NASDAQ.
Key slides for Xeris Biopharma Holdings Inc
Corporate Presentation
Xeris Biopharma Holdings Inc
Corporate Presentation
Xeris Biopharma Holdings Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
XERS
Country
🇺🇸 United States